Lung Cancer: Diagnosis


CT Screening Can Detect Lung Cancer Sooner

The National Lung Screening Trial (NLST) recently released results showing there were 20 percent fewer deaths from lung cancer among people who were screened with low-dose helical (spiral) CT than with chest X-ray. Using these CT scans, researchers were able to find lung cancer at an early stage. Because the disease was found early, the patients had more treatment options.

This study, funded by the National Cancer Institute (NCI), looked at 53,000 current and former heavy smokers between the ages of 55 to 74 from around the country

Heavy smokers have a higher risk of disease from many other types of cancers, heart disease and lung disease. The patients in the helical CT group had a 7 percent lower death rate from all causes than the group that received a chest X-ray. For every 300 NLST participants screened with CT, one life has been extended.

Because of this difference in survival, the National Cancer Institute decided to end its NLST study. The patients in the chest X-ray group were informed of these results and encouraged to discuss with their physicians whether they should undergo a CT screening.

Visit the National Cancer Institute website for further information regarding this study.

Read a paper describing the study design on the Radiology website.

 

National Jewish Health now offers low-dose helical CT screening to patients at high risk for lung cancer.

Connect with Us Online


Become our fan on facebook!   Subscribe to our YouTube channel!   Follow us on Twitter!   Subscribe to our News RSS feed.

eNewsletters and More

Lung Cancer Center


As the #1 respiratory hospital in the country, National Jewish Health offers expertise on all lung conditions, including the leading cause of cancer-related deaths—lung cancer. Learn more.

Detecting Lung Cancer Early


Lung cancer is highly treatable if it is caught early. Survival rates climb dramatically with early diagnosis, to around 80 percent for localized, stage I cancers. We can help. Read more.